Nucleus Biologics Continues To Feed Scientific Breakthrough With Unprecedented Two-Year, Fixed-Price Guarantee On Premium Fetal Bovine Serum For Scientists

SAN DIEGO--(BUSINESS WIRE)--Nucleus Biologics, a cell culture products supplier to the biotech and pharmaceutical industries, has announced a two-year, fixed-price guarantee for its premium fetal bovine serum (FBS) via its exclusive and consistent source in Australia. The offer is extended to new and existing Nucleus Club members. This stable supply of fixed-price, low-viral risk FBS is particularly important in large scale bioproduction or research applications such as vaccines, stem cell therapies, antibodies, CAR-T cells, immunotherapies or any sensitive scientific experiments.

Nucleus Biologics recognized a major challenge in cell culture – FBS creates a variable that is not under the control of the research scientist. Drastic fluctuations in FBS supplies create volatility in the market, inconsistent quality and pricing spikes. Because FBS is a byproduct of the meat industry, production is influenced by numerous variables including weather, food supply, disease, economic conditions and the size of herds. With FBS prices constantly fluctuating, it is difficult for companies to secure consistent supply or anticipate prices they’ll actually end up paying for FBS when planning scale-up or ongoing development. A long-term, fixed-price supply eliminates this guesswork and increases the likelihood of project consistency.

Nucleus Biologics addresses this challenge by controlling its FBS supply chain and working under exclusive, single-source provider agreements. This enables the company to guarantee specific volume needs and fixed-pricing without the risks associated with multiple outside providers, processers or middlemen. Quality is assured as well with a serum that is consistent across lots with Farm-to-Flask^TM traceability back to the animal. Nucleus Biologics FBS is also characterized with over 65 tests that include biochemical, hormonal, viral and functional profiles, and is FMD- and BSE-free due to the dedicated source in Australia.

Nucleus Biologics FBS is manufactured under a controlled and transparent process yielding an extremely low viral load, low hemoglobin and low endotoxin serum. The FBS is processed in a facility that is FDA registered, ISO 9001:2008 certified and follows cGMP.

According to Nucleus Biologics Chief Executive Officer David Sheehan, “We are fundamentally redesigning the FBS supply chain. We believe the short-term agreements and a commodity mindset have created a volatile product that does not serve scientists. By partnering with our supplier, we can better live up to our mission to provide the highest quality cell culture solutions to feed scientific breakthrough. The formation of the Nucleus Club and our fixed-price agreements will be especially valuable for companies involved in bioproduction.”

Nucleus Club members gain first access to new products, free storage, free shipping, and a fixed-price guarantee for up to two years. For information on the Nucleus Club contact Alyssa Master. Click here to order a free FBS sample.

About Nucleus Biologics

Nucleus Biologics is a San Diego-based supplier of premium cell culture products for biotech and pharmaceutical companies throughout North America. The company feeds scientific breakthrough by partnering with the source and redesigning the traditional cell culture products supply chain for greater transparency and superior quality. Nucleus Biologics’ premier product offering is an exceptionally low-viral load, Australian-based fetal bovine serum (FBS) that is consistent, traceable to a single source, characterized and provides stable supply and pricing. Nucleus Biologics partners with Australian Agricultural Company (AACo) as its exclusive source in Australia. AACo has the largest herd in Australia and over 16 million acres of land under its control. Numerous other product offerings are planned throughout 2017. Visit us on Facebook, LinkedIn and Twitter. www.nucleusbiologics.com. Call us at 858.251.2010.